Are Missed- and Kept-Visits-Based Measures Capturing Different Aspects of Retention in Care?

Similar documents
Johns Hopkins University, 6 Health Resources and Services Administration, 7

The Contribution of Missed Clinic Visits to Disparities in HIV Viral Load Outcomes

A Low-Effort, Clinic-Wide Intervention Improves Attendance for HIV Primary Care

Elements of the Care Continuum

Retention in HIV care predicts subsequent retention and predicts survival well after the first year of care: a national study of US Veterans

Single Viral Load Measurements Overestimate Stable Viral Suppression Among HIV Patients in Care: Clinical and Public Health Implications

The effect of depression on missed HIV medical visits among patients in the CFAR Network of Integrated Systems (CNICS) cohort in the United States

Retention in HIV Care

Linkage to care and initiating ART after diagnosis with acute or established HIV infection in 8 US emergency departments

Changes in viral suppression status among US HIV-infected patients receiving care

Clinical Infectious Diseases Advance Access published August 4, Beyond Core Indicators of Retention in HIV Care: Missed Clinic Visits

Measure #340 (NQF 2079): HIV Medical Visit Frequency - National Quality Strategy Domain: Efficiency And Cost Reduction

HIV/AIDS Bureau Update

Evidence-based Strategies to Address Retention in HIV Care

Evaluating Retention in Medical Care and its Impact on the Health Outcomes of Individuals Living with Human Inmmunodeficiency Virus

We Are Going to Need a Bigger Wrench: Improving Linkage and Retention in HIV Care

Health Resources and Services Administration and HIV/AIDS Bureau Update

Incidence of Primary Liver Cancer in American Indians and Alaska Natives

Antiretroviral prescription delivery for persons living with HIV/AIDS in Alabama:

Please dial: Participant Code: for the audio portion of this conference.

Using Mobile Technology with ARTAS Interventions STEVE DELLINGER, COMMUNITY HEALTH EDUCATOR ALABAMA DEPARTMENT OF PUBLIC HEALTH

Adherence and HIV Suppression after Behavioral Intervention in Patients with Elevated Viral Load

Didactic Series. Update on DHHS Guidelines for HIV Treatment: Adherence to the Care Continuum

Disparities in HIV Care. Slides prepared by Kirk Fergus, Intern National Quality Center

IMPROVING HIV HEALTH OUTCOMES FROM A PERSON-CENTERED APPROACH

National HIV/AIDS Strategy

October, November, & December 2016 Ministry Schedule

The relationship between adherence to clinic appointments and year-one mortality for HIV infected patients at a Referral Hospital in Western Kenya

REFLECTIONS ON ADHERENCE 2017 MICHAEL STIRRATT PHD NIMH DIVISION OF AIDS RESEARCH JUNE

IAPAC 11 th International Conference on HIV Treatment and Prevention Adherence Fort Lauderdale, FL May 11, 2016

HIV/AIDS CLINICAL CARE QUALITY MANAGEMENT CHART REVIEW CHARACTERISTICS OF PATIENTS FACTORS ASSOCIATED WITH IMPROVED IMMUNOLOGIC STATUS

ROKSANA KARIM, MBBS, PHD UNIVERSITY OF SOUTHERN CALIFORNIA LOS ANGELES, CA

ENTRY INTO AND RETENTION IN CARE AND MONITORING ANTIRETROVIRAL ADHERENCE FOR PERSONS WITH HIV

HIV / AIDS Quality Measures AMA/NCQA/HIVMA/IDSA/HRSA and NQF Endorsed

HIV treatment interruptions are associated with heightened biomarkers of inflammation, coagulopathy and T-cell activation despite viral suppression

Gender Disparities in Viral Suppression and Antiretroviral Therapy Use by Racial and Ethnic Group Medical Monitoring Project,

Peter Messeri Robert Frey Gunjeong Lee

A Trauma-Informed Approach to Serving HIV+ Women with Co-Occurring Disorders & their Affected Children

Using HIV Surveillance Laboratory Data to Identify Out-of-Care Patients

Uptake of Pre-exposure Prophylaxis (PrEP) in Young Men Who Have Sex with Men is Associated with Race, Sexual Risk Behavior and Network Size

Health Literacy, Numeracy and HIV Outcomes

Surveillance-Based Re-linkage to HIV Care: The King County Experience

CDC Review and Dissemination of Evidence-based HIV Treatment Adherence Interventions

Engagement is Key to Effectiveness of Individualized Texting for Adherence Building (itab) Among HIV+ Methamphetamine Users

Relationships of HIV- and Race-Based Discrimination to Antiretroviral Treatment Use and Retention in Care among African Americans with HIV

Objectives. Distinguish between primary and secondary studies. Discuss ways to assess methodological quality. Review limitations of all studies.

in+care Campaign: Improving Retention in HIV Care

The Iowa State Bar Association 2008 Judicial Plebiscite

HIV QUALITY MANAGEMENT PLAN Updated April 2011

HRSA HIV/AIDS Bureau Updates

2018 IRLT Gator Gallop 5K Age Group Results

Understanding the Disparity: Predictors of Virologic Failure in Women using HAART vary by Race/Ethnicity

Symptom prevalence and help seeking among patients at risk of lung cancer: An exploratory feasibility study in a primary care population

GOAL1 GOAL 2 GOAL 3 GOAL 4

Women with a history of injection drug use at greatest risk for poorer clinical outcomes in a cohort of HIV-positive individuals in Canada

Zero HIV infections Zero HIV deaths Zero HIV stigma. Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium

Enhancing PrEP Access for Black and Latino Men Who Have Sex with Men

Sion K. Harris, PhD, Lon Sherritt, MPH, Erin B. Gibson MPH, Laura Grubb, MD MPH, Ronald Samuels, MD, Thomas Silva, MD, Louis Vernacchio, MD MSc,

The effect of systemic exposure to efavirenz, sex and age on the risk of virological nonsuppression in HIV-infected African children.

Changes in HIV Providers Management of Depression after Integration of Treatment Support into Clinical Care

Peter Messeri Robert Frey Gunjeong Lee

Positive Connections Ad Hoc Committee Meeting 9:30 am, Wednesday, October 18, 2017 Meeting Location: 2223 West Loop South, Room 416, Houston, TX 77027

Socioeconomic Vulnerabilities and Disparities in Preterm Birth Rates: Analysis of Mississippi Counties POPULATION BRIEF

JAIDS SUPPLEMENT DISCUSSION

Women and HIV: The U.S. Perspective

State of Alabama HIV Surveillance 2014 Annual Report

Audit. Public Health Monitoring Report on 2006 Data. National Breast & Ovarian Cancer Centre and Royal Australasian College of Surgeons.

Northumberland Special Olympics Regional Gala 2013 at Blyth Sports Centre RESULTS

HIV care engagement among people with a history of injection drug use

Class 7 Everything is Related

Concept Paper. Developing a National Quality Improvement Campaign

Initiation and engagement in addiction treatment integrated into primary care: the role of gender

Engagement in Outpatient Care for Patients Living with HIV (PLWH)

HIV/AIDS AND CULTURAL COMPETENCY

Gender and Sexual Health Initiative, BC Centre for Excellence in HIV/AIDS, Vancouver, Canada

Mirjam-Colette Kempf, PhD, MPH UAB School of Nursing nd Avenue South, NB 1019D Birmingham, AL

The Effect of Antidepressant Treatment on HIV and Depression Outcomes: Results from the SLAM DUNC Randomized Controlled Trial

Mental health service utilization is associated with retention in care among persons living with HIV at a university affiliated HIV clinic

DSS RULES/MOTIONS 2:30 PM 5:00 PM

Everything Comes Down to This Systems Linkages and Access to Care for Populations at High Risk for HIV Infection in New York State

Evaluating HIV Clinical Care Quality in the Massachusetts Sites supported through the Medical Case Management System Results from review

USING A QUALITY IMPROVEMENT COHORT MODEL TO ACHIEVE HEALTH EQUITY

L2C IN NYC RYAN WHITE PART A PLANNING COUNCIL INTEGRATION OF CARE COMMITTEE DECEMBER 3 RD, DECEMBER 17 TH 2014

Follow-up investigation of a cluster of treatment-naïve HIV-infected patients with multi-drug resistance in Sudbury, Ontario

DiabetesAgent.org: Development and evaluation of a dashboard to improve diabetes patient appointment efficacy

Utilization of OncoType DX Test for

Active Methamphetamine Use is Associated with Antrietroviral Medication Nonadherence

Short-term Navigation successful at re-engaging patients in care

Boston EMA Ryan White Part A Integrated HIV Prevention and Care Plan. September 8 th, 2016

Alexander Lankowski 1, Cedric Bien 1,2, Richard Silvera 1,2, Viraj Patel 1, Uriel Felsen 3, Oni Blackstock 1

New England healthcare providers perceptions, knowledge and practices regarding the use of antiretrovirals for prevention

CONTEST SCORE REPORT SUMMARY FOR GRADES 6, 7, AND 8 Summary of Results 6th Grade Contests ALML

High Impact Prevention: Science, Practice, and the Future of HIV

Risk of Seizures following Measles Containing Vaccination in Children Born Preterm or Full-term

Recent Breakthroughs in HIV Prevention for Men who Have Sex with Men and Transgender Populations

Medical Mistrust Predicts Lower Longitudinal Medication Adherence Among African American Men

Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users

Keeping Youth in Care

Adverse Reactions to HIV Vaccines: Medical, Ethical, and Legal Issues. September OTA-BP-H-163 GPO stock #

Transcription:

Are Missed- and Kept-Visits-Based Measures Capturing Different Aspects of Retention in Care? D. Scott Batey, 1 Andrew Westfall, 1 Anne Zinski, 1 Thomas Giordano, 2 Mari-Lynn Drainoni, 3 Tracey Wilson, 4 Jeanne Keruly, 5 Allan Rodriguez, 6 Michael Mugavero 1 on behalf of the Retention in Care (RIC) Study Group* 1 University of Alabama at Birmingham, 2 Baylor College of Medicine, 3 Boston University Medical Center, 4 State University of New York, Downstate Medical Center, 5 Johns Hopkins University, 6 University of Miami The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention

Measuring retention in care is complex Multiple visits at varying intervals over time Numerous retention measures employed Missed visit ( no show ) & kept visit measures Each associated w/ biological & clinical outcomes Degree to which measures are related to one another is largely unexplored

Measure Missed visits: count Missed visits: dichotomous Visit adherence 4-month constancy 6-month gap HRSA HAB Description Number of no show visits accrued (count measure) 1 no show visit (dichotomous measure, no = retained) Proportion of kept visits / (kept + no-show visits) (continuous measure, range=0.0-1.0) Number of 4-month intervals with at least 1 kept visit (categorical measure, range=0-3) 189 days elapsed between sequential kept visits (dichotomous measure, no = retained) 2 kept visits separated by 90 days (dichotomous measure, yes = retained)

Spearman rank correlation matrix Mugavero, et al., JAIDS 2012; 61

Association of retention measures with 12-month VL suppression (<400 c/ml) a OR presented per missed visit (count), per 0.5 increase for visit adherence & 4-month constancy, and retained for dichotomous retention measures: missed visits, 6-month gap, and HRSA HAB measure b Sn and Sp for cut-points for retained of: 1 missed visits (count), 70% visit adherence, and attended visits in all 3 intervals for 4-month constancy, and per retained for dichotomous measures Mugavero, et al., JAIDS 2012; 61

Are Missed- and Kept-Visits- Based Measures Capturing Different Aspects of Retention in Care?

Methods Study aims: Evaluate differences in association of social demographics among 6 retention measures Design: Retention in Care (RIC) Intervention Study Six academically-affiliated HIV clinics Phase I (Clinic-wide) & Phase II (Behavioral RCT) Current study: Clinic-wide cohort design during 12 months preceding Phase I RIC intervention

Methods Study period: May 2008 April 2009 Eligibility criteria: Attended 1 primary HIV care appointment in the year preceding study period 1 scheduled primary HIV care appointment during 1 st six months of study period Criteria employed to identify established clinic patients in whom retention could be measured

Methods Principal outcome: Six commonly used retention measures Scheduled visits w/ primary HIV medical provider Calculated based upon kept and no show visits Principal exposures: Social demographics Statistical analyses: Multivariable regression for each measure

Methods: Retention Measures Measure Description Modeling Approach Missed visits: count Missed visits: dichotomous Visit adherence Number of no show visits accrued (count measure) 1 no show visit (dichotomous measure, no = retained) Proportion of kept visits / (kept + noshow visits) (continuous measure, range=0.0-1.0) Poisson Logistic OLS, Beta

Methods: Retention Measures Measure Description Modeling Approach Missed visits: count Number of no show visits accrued (count measure) Poisson Missed visits: dichotomous Visit adherence 4-month constancy 6-month gap HRSA HAB 1 no show visit (dichotomous measure, no = retained) Proportion of kept visits / (kept + noshow visits) (continuous measure, range=0.0-1.0) Number of 4-month intervals with at least 1 kept visit (categorical measure, range=0-3) 189 days elapsed between sequential kept visits (dichotomous measure, no = retained) 2 kept visits separated by 90 days (dichotomous measure, yes = retained) Logistic OLS, Beta Ordinal logistic, multinomial logistic, OLS Logistic Logistic

Baseline characteristics (n=10,053)

Baseline characteristics (n=10,053) Data presented as mean + standard deviation or n (%)

Baseline characteristics (n=10,053) Data presented as mean + standard deviation or n (%)

Disparities in Retention Missed visits Male 1.26 (1.15, 1.37) Black/AA 0.57 (0.52, 0.62) IVDU 0.68 (0.60, 0.78) Appt. adherence 0.02 (0.01, 0.03) -0.06 (-0.08, -0.05) -0.05 (-0.06, -0.03) Data presented for retained for missed visit dichotomous (OR), visit adherence (β-coefficient), 4-month constancy (OR for ordinal regression), 6-month gap (OR), and HRSA HAB measure (OR)

Disparities in Retention? Missed visits Appt. adherence 4-mo visit constancy 6-mo gap HRSA HAB Male 1.26 (1.15, 1.37) 0.02 (0.01, 0.03) 0.90 (0.83, 0.97) 0.94 (0.86,1.03) 0.92 (0.83,1.01) Black/AA 0.57 (0.52, 0.62) -0.06 (-0.08, -0.05) 1.01 (0.93,1.10) 0.97 (0.88-1.06) 0.98 (0.88-1.08) IVDU 0.68 (0.60, 0.78) -0.05 (-0.06, -0.03) 0.99 (0.88, 1.10) 1.03 (0.91, 1.17) 0.91 (0.79, 1.04) Data presented for retained for missed visit dichotomous (OR), visit adherence (β-coefficient), 4-month constancy (OR for ordinal regression), 6-month gap (OR), and HRSA HAB measure (OR)

Are Missed- and Kept-Visits- Based Measures Capturing Different Aspects of Retention in Care?

Conclusions Considerable variability among six measures in categorizing retention Measures were differentially associated with gender, race, and HIV risk. Associations were congruent within related measure groups (missed and kept)

Limitations Observational study: cannot ascribe causality Exclusion of patients new to care Relatively short observation period

Implications No gold standard for measuring retention Interpretation of findings may vary dependent on chosen retention measure, even in identical samples Careful attention is warranted when comparing findings across study, data, and setting system with regards to measure(s) used

Acknowledgments Boston University Medical Center Mari-Lynn Drainoni (PI) Cintia Ferreira Lisa Koppelman Maya McDoom Michal Naisteter Karina Osella Glory Ruiz Paul Skolnik Meg Sullivan (PI) SUNY Downstate Medical Center Sophia Gibbs-Cohen Elana Desrivieres Mayange Frederick Kevin Gravesande Susan Holman Harry Johnson Tonya Taylor Tracey Wilson (PI) University of Alabama-Birmingham Scott Batey Stephanie Gaskin Michael Mugavero (PI) Jill Murphree Jim Raper Michael Saag (PI) Suneetha Thogaripally James Willig Anne Zinski Baylor College of Medicine Monisha Arya David Bartholomew Tawanna Biggs Hina Budhwani Jessica Davila Christine Jacobsen Tom Giordano (PI) Nancy Miertschin Shapelle Payne William Slaughter Johns Hopkins University Mollie Jenckes Jeanne Keruly (PI) Angie McCray Mary McGann Richard Moore (PI) Melissa Otterbein LiMing Zhou University of Miami Carolyn Garzon Jesline Jean-Simon Kathy Mercogliano Lisa Metsch (PI) Allan Rodriguez (PI) Gilbert Saint-Jean Marvin Shika Mountain Plains AETC Lucy Bradley-Springer Marla Corwin Federal Laura Cheever, HRSA Faye Malitz, HRSA Robert Mills, HRSA Jason Craw, CDC/ICF Lytt Gardner, CDC Sonali Girde, CDC/ICF Gary Marks, CDC We thank the study participants, providers, clinical and research personnel at the six study sites as well as the CDC and HRSA administrative and data management teams. Supported by CDC & HRSA via CDC contracts: 200-2007-23685, 200-2007-23690, 200-2007-23689, 200-2007-23687, 200-2007-23684, 200-2007-23692. MJM supported by 5K23MH082641-05